跳至主要内容
临床试验/ACTRN12619000997156
ACTRN12619000997156已完成未知

on-Alcoholic Fatty Liver Disease (NAFLD): the feasibility of two different weight loss dietary approaches

niversity of Otago0 个研究点目标入组 20 人开始时间: 2019年7月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
20 Years 至 65 Years(—)
性别
All

入选标准

  • NAFLD defined using the 2012 American Diagnosis and Management of Non-alcoholic Fatty Liver Disease Practice Guidelines (In summary, a diagnosis of NAFLD requires evidence of hepatic steatosis either by imaging or histology, and no causes for secondary hepatic fat accumulation (e.g. excess alcohol intake, hepatitis B or C).
  • Dunedin resident men and women
  • aged 20-65 years
  • overweight or obese (BMI greater than or equal to 25kg/m2)

排除标准

  • patients with type 1 diabetes
  • patients with type 2 diabetes using insulin
  • those with a terminal illness
  • pregnant women
  • lactating women
  • those unwilling to attempt to comply with intensive dietary advice
  • any contraindications to having magnetic resonance scanning including claustrophobia

研究者

相似试验